Enteral administration of GOS/FOS decreased terminal ileum IL1β and TNFα protein levels and the mRNA expression of several pro-inflammatory cytokines including IL6, IL1β and TNFα in a rat NEC model [136]. This evidence concerns the gene IL1B and necrotizing enterocolitis.